Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Switzerland
Biotech
South Korean biotech group spies US SPAC as route to Nasdaq
OSR Holdings is the latest biotech business to choose a merger with a special purpose acquisition company as a way to hop onto the public markets.
James Waldron
Jul 12, 2023 8:45am
BC Platforms acquires CRO 4Pharma for undisclosed price
Jun 14, 2023 4:05pm
Spexis narrows focus to keep lights on into 2023
Jul 28, 2022 8:45am
Swiss biotechs see record breaking revenue, R&D investment
May 4, 2022 8:12am
Distalmotion nets $90M to take its surgery robot to FDA
Jan 26, 2022 10:55am
After Wegovy win, Novo extends obesity research in EraCal collab
Jan 17, 2022 5:05am